LGVN vs VRTX: Which Stock is Better?
Side-by-side comparison of Longeveron Inc and Vertex Pharmaceuticals Inc in 2026
LGVN
Longeveron Inc
$1.10
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | LGVN | VRTX | Winner |
|---|---|---|---|
| Market Cap | $32.21M | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | -0.4% | 0.1% | VRTX |
| Gross Margin | 67.0% | 53.7% | LGVN |
Analyze LGVN
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LGVN or VRTX a better investment?
Comparing LGVN and VRTX: Longeveron Inc has a market cap of $32.21M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LGVN and VRTX?
LGVN (Longeveron Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LGVN or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LGVN or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.4% for LGVN.
Which company is more profitable: LGVN or VRTX?
Longeveron Inc (LGVN) has higher gross margins at 67.0% compared to 53.7% for VRTX.
Which is the larger company: LGVN or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $32.21M for LGVN.
Should I buy LGVN or VRTX in 2026?
Both LGVN and VRTX have investment merit. LGVN trades at $1.10 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LGVN and VRTX stock?
Key differences: Market Cap ($32.21M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (-0.4% vs 0.1%), Gross Margin (67.0% vs 53.7%).